semaglutide pharmacokinetics subcutaneous is a medication typically prescribed for Type 2 diabetes; however, it has gained recent popularity as a weight-loss medication. Learn more from Bryan Kuhn, PharmD, DABAT, Clinical Educator at the Banner semaglutide phase 1 Pharmacokinetics, Safety

Ko JW, Park KD, Lee Y, Lee JH, Hong DK

Short-term effects (first 12 weeks) Injection-site irritation : redness, itching, or swelling Headaches or nausea : usually mild and temporary Fatigue or drowsiness : some people feel extra tired at the start Water retention or bloating : often resolves as your body adjusts Occasional but less common effects Joint stiffness or aches Tingling or numbness (paresthesia, often in the hands or feet) Increased appetite These usually fade as your body adapts, but if they linger, its worth checking in with your provider

Mounjaro is made by Eli Lilly and contains the same active ingredient (tirzepatide) as Zepbound

Two people can take the same drug with very different results